Literature DB >> 35024069

Role of sildenafil in a neonate with double outlet left ventricle and pulmonary hypertension.

Pezad Doctor1, Jennifer Blake2, Sanjeev Aggarwal2.   

Abstract

Double outlet left ventricle (DOLV) is a rare congenital heart defect where the aorta and the pulmonary trunk arise predominantly from the morphologic left ventricle. The clinical manifestations depend upon the location of the ventricular septal defect in relation to the great arteries, degree of pulmonary and aortic outflow tract obstruction, and other associated cardiac defects. We describe a neonate with DOLV, sub-aortic ventricular septal defect, and side-by-side great vessels who continued to require oxygen for desaturation to 60% in the neonatal period. His clinical symptoms were suggestive of persistent pulmonary hypertension, with 5-8% higher saturations in the leg compared to arm. He was started on oral sildenafil and his oxygen requirement decreased from 2 L/min to 0.1 L/min within 24 hours of initiating sildenafil. <Learning objective: The clinical manifestation of double outlet left ventricle mimic transposition of great vessels, tetrology of Fallot, or ventricular septal defect depending upon the cardiac lesion. The use of sildenafil has been expanded in the management of infants with non-cardiac as well as cardiac-related pulmonary hypertension. Sildenafil was successfully used in an infant with double outlet left ventricle, sub-aortic ventricular septal defect and rightward aortic root in the management of increased oxygen requirement attributed to pulmonary hypertension. However, close monitoring is required due to the risk of pulmonary over circulation.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Double outlet left ventricle; Pulmonary hypertension; Sildenafil

Year:  2021        PMID: 35024069      PMCID: PMC8721246          DOI: 10.1016/j.jccase.2021.06.005

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  6 in total

Review 1.  Cyclic GMP phosphodiesterase-5: target of sildenafil.

Authors:  J D Corbin; S H Francis
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  Persistent pulmonary hypertension of the newborn with transposition of the great arteries.

Authors:  Marcus T R Roofthooft; Klasina A Bergman; Tjalling W Waterbolk; Tjark Ebels; Beatrijs Bartelds; Rolf M F Berger
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

3.  Pulmonary vascular disease in complete transposition of the great arteries: a study of 200 patients.

Authors:  E A Newfeld; M M Paul; A J Muster; F S Idriss
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

Review 4.  Congenital Heart Surgery Nomenclature and Database Project: double outlet left ventricle.

Authors:  C I Tchervenkov; H L Walters; V F Chu
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

5.  Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.

Authors:  Christian Stocker; Daniel J Penny; Christian P Brizard; Andrew D Cochrane; Rodrigo Soto; Lara S Shekerdemian
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440

6.  Persistent Pulmonary Hypertension of the Newborn with D-transposition of the Great Arteries: Management and Prognosis.

Authors:  Salaam Sallaam; Girija Natarajan; Sanjeev Aggarwal
Journal:  Congenit Heart Dis       Date:  2015-11-11       Impact factor: 2.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.